Compare BVS & BOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BVS | BOT |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | Puerto Rico |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 783.2M | 706.0M |
| IPO Year | 2016 | N/A |
| Metric | BVS | BOT |
|---|---|---|
| Price | $11.85 | $24.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 706.8K | 631.0K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 163.46 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $568,087,000.00 | N/A |
| Revenue This Year | $7.52 | N/A |
| Revenue Next Year | $7.06 | N/A |
| P/E Ratio | $287.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.81 | $25.27 |
| 52 Week High | $12.53 | $43.72 |
| Indicator | BVS | BOT |
|---|---|---|
| Relative Strength Index (RSI) | 58.18 | 40.27 |
| Support Level | $8.04 | N/A |
| Resistance Level | $12.53 | $36.35 |
| Average True Range (ATR) | 0.54 | 3.06 |
| MACD | -0.07 | -0.99 |
| Stochastic Oscillator | 41.30 | 7.79 |
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
RoboStrategy Inc is a closed-end, non-diversified management investment company. The Fund's investment objective is to seek long-term capital appreciation, principally through capital gains on equity and equity-linked investments in robotics and embodied AI companies. The Fund focuses on private, venture-capital-backed companies with growth potential, many of which are not yet publicly listed or widely accessible to individual investors.